Abstract
Pre-existing autoimmune disease during pregnancy is infrequent occurring in 1.0-2.0% of pregnant women. Autoimmune diseases (ADs) are not lethal and can co-exist with other autoimmune types. In the present report, ADs were found to produce false positive maternal serum screens for both neural tube defects and Down syndrome. The course of ADs is highly influenced by maternal and placental proteins, hormonal factors, and cytokines. Such agents appear to serve as protective factors at the induction and effector stages of the immune response during pregnancy. During second and third trimester pregnancies and in postpartum, autoimmune-afflicted patients experience stages of remissions and relapses. Most remissions occur in the second and third trimesters when soluble immunoprotective factors attain peak levels. Some plausible immunosuppressive factors include quad biomarkers and pregnancy associated glycoproteins such as alpha-fetoprotein, human chorionic gonadotrophin, dimeric inhibin-A, and unconjugated Estriol. The mechanism of remission of ADs is not fully understood but is associated with induction of an immunosuppressive and/or immunotolerant state coincident with the presence of known and unknown soluble factors.
Keywords: Alpha-fetoprotein, autoimmunity, dimeric inhibin, human chorionic gonadotrophin, pregnancy, unconjugated Estriol.
Graphical Abstract
Call for Papers in Thematic Issues
RARE CASES IN GYNECOLOGY-OBSTETRICS
With the development of diagnostic and therapeutic techniques (such as ART techniques) and the immersion of new pathologies (such as COVID19), we are witnessing an increase in the incidence of pathologies that were previously described as rare or exceptional. the practitioner sometimes confronts difficult situations in these cases in diagnostic ...read more
37